TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: sensitivity for detecting suspicious breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety and tolerability of BG505 SOSIP.664 gp140 Vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Analog Mood Scale (AMS) Anxiety Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Normalized Response Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin tolerability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative changes in the plasma levels of C-terminal telopeptide of type I collagen (CTX-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Relative changes in the plasma levels of N-terminal propeptide of type I procollagen (P1NP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of on-treatment pregnancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Tendon and ligament abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Occurrence of a relapse
Endpoint domain: Adverse events/effects
Primary endpoint: noninvasive blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Integrated pulmoner index (IPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Reading Accuracy
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Reading Speed
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Haemoglobulin-corrected carbon monoxide diffusing capacity (DLCOc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Distance (meters) in 6-minute walk test (6MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of skin barrier
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Cardiovascular risk as assessed by Modified Moli-Sani risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Long-term CV clinical outcome at 7 years follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MET
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in breast cancer risk estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cerebral oxygenation and hemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in small bowel injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 1st Measurement
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Change in margin status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: % of patients with successful cannulation in first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Participants With Plasma HIV-1 RNA ≥50 c/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of patients receiving therapy according to iLTB advice
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Functional Living Index-Emesis (FLIE score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accuracy of scanning device to predict clinically significant Cobb Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute Bioavailability (F) of LOXO-783
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type and incidence of Treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of patients achieving PSA < 0.2 ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change From Baseline in IDS-SR-10 Engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in IDS-SR Total Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Surgical Conversion Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Uptake of prophylactic prostatectomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CCL14 concentration in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of developmental delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Contamination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mitral valve effective regurgitant orifice area change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in VAS-3 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of the Gilbert Laboratories pocket valve spray
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Irritation Potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: serum concentration of cardiac biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Probability of graft survival
Endpoint domain: Mortality/survival
Primary endpoint: Probability of patient survival
Endpoint domain: Mortality/survival
Primary endpoint: Self-assessment score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety, including reactogenicity
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity- neutralizing antibody response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Effect on intestinal microbial populations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Functional Outcomes of Sleep Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Continuous Positive Airway Pressure (CPAP) Adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Tremor Research Group Essential Tremor Rating Assessment (TETRAS) Performance Subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression of Severity (CGI-S)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Levels of miR-27 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of FSTL1 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cholinergic terminal density change between baseline and 18-months follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in overall cognitive functioning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Attention/working memory change from baseline to 18-months follow-up as measured by the Trail Making A Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patients' ability to drink the specified daily amount of 750 ml human lysozyme goat milk (hLZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TFR rate at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of TEAEs (Treatment-emergent adverse events)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with DTLs (dose-limiting toxicities)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with grade ≥ 3 TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Variation in spinal angle measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Safety and tolerability after hAMSCs injection
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio of transplantable embryo in DOR patients after hAMSCs injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Difficulties and specific needs of a caregiver
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: patients perceived FHPs' sharing bad news performance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Participants with AEs resulting in Death
Endpoint domain: Adverse events/effects
Primary endpoint: booster take-up at UCLA/CVS in 2 weeks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: booster take-up at UCLA/CVS in 4 weeks
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative survival time
Endpoint domain: Mortality/survival
Primary endpoint: MAIT cells frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity and specificity of High-Res-OCT for retinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in absolute walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-yr progression free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: stem cell collection failure rate
Endpoint domain: Adverse events/effects
Primary endpoint: Radiographic evaluation of bone height
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Radiographic evaluation of bone density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of participants who experience a dose limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who achieve a complete response (CR), partial response (PR), or minor response (MR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of participants who achieve a complete response (CR) or partial response (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Female Sexual Function (FSFI)
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Subjective Pelvic Perineal Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve from time 0-infinity (AUC0-inf) of DOR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of doravine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration at 24 hours postdose (C24) of DOR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of interpretation errors
Endpoint domain: Adverse events/effects
Primary endpoint: Effect of ectopic pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fat-phobia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Weight Implicit Association
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in patient reported anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in patient reported depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in single limb stand time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in balance self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in Dosing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Mood and Anxiety Rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: [11C]UCB-J volume of distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emotional Distress, Anxiety and Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of relapse after discharge from the treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Treatment-Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline on the Mood and Anxiety Symptom Questionnaire General Distress Subscale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline fMRI activation to emotional stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline fMRI resting state connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: GSRS Constipation Syndrome Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in serum parathyroid hormone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Numeric Pain Rating Scale (NRPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Change in Pain Relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Atrial fibrillation recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-ablation quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ovulation frequency within 5 days of implant insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Lipopolysaccharide-binding protein (LBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in relative abundance of FP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in relative abundance of AM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tumor specific lighting ability of [68Ga]-NOTA-SGC8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of treatment-related adverse events of [68Ga]-NOTA-SGC8
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Pain on the Visual Analogue Scale (VAS scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Knee Range Of Motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in WOMAC Total score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Rate of successful defibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: OCD symptoms severity T1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OCD symptoms severity T2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depressive symptoms severity T1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: depressive symptoms severity T2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving low disease activity (LDA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients who experience major complications
Endpoint domain: Adverse events/effects
Primary endpoint: Motor Flexibility Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of type of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of frequency of AEs
Endpoint domain: Adverse events/effects
Primary endpoint: CBCT measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: suture opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Nasal CXCL10 gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse events in each study arm
Endpoint domain: Adverse events/effects
Primary endpoint: Time to completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rotavirus diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Infection of the upper respiratory tract
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants with Recurrent Ischemic Stroke
Endpoint domain: Mortality/survival
Primary endpoint: Variation in mental workload
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Area Under the Plasma Concentration-Time Curve of Lu AG06466 and Metabolite Lu AG06988 From Zero to Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Lu AG06466 and Metabolite Lu AG06988
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ictal thalamic involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Epileptogenicity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Interictal power distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Single pulse electrical stimulation (SPES)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Uncorrected Visual Acuities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corrected Visual Acuities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective quality of vision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive Appraisal of Health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dental plaque scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence of treatment discontinuation due to toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Speech ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants Who Completed an Adolescent Well-care Visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: degree of agreement in cardiac output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of adhesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The McGill pain questionnaire (MPQ)
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: The Endometriosis Health profile (EHP30) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of patients with drug related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in 24hr average glucose AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection of brain specific biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Distinction of pathologic and physiologic biomarker patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Columellar Deviation Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasolabial Groove Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Water Station Usage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dental Caries Status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants completing study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients with HBs antibody levels > 10mUI/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: spinal needle-puncture pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptance and Retention of Mothers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Determinants of Implementation Behavior Questionnaire (DIBQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived Change for Better Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Target behaviors
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pain in postoperative period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Union (Healing)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the daily eating window
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's vaccination uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes